thalidomide has been researched along with leptin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brenne, AT; Hjorth-Hansen, H; Iversen, PO; Olstad, OK; Reppe, S; Reseland, JE; Syversen, U; Waage, A | 1 |
Bartchewsky, W; Carvalho, Pde O; Cintra, DE; Compri, CM; Fornari, JV; Gambero, A; Pedrazzoli, J; Pinto, Lde F; Ribeiro, ML; Saad, MJ; Trevisan, M; Velloso, LA | 1 |
1 trial(s) available for thalidomide and leptin
Article | Year |
---|---|
Abnormal adipokine levels and leptin-induced changes in gene expression profiles in multiple myeloma.
Topics: Adiponectin; Cell Line, Tumor; Energy Metabolism; Female; Gene Expression Regulation, Neoplastic; Humans; Immunosuppressive Agents; Leptin; Male; Multiple Myeloma; Resistin; Thalidomide | 2009 |
1 other study(ies) available for thalidomide and leptin
Article | Year |
---|---|
The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high-fat diet in mice.
Topics: Animals; Biopsy, Needle; Blood Glucose; Diet; Dietary Fats; Disease Models, Animal; Fatty Liver; Immunohistochemistry; Immunosuppressive Agents; Inflammation Mediators; Insulin Resistance; Interleukin-6; Leptin; Liver; Liver Function Tests; Male; Mice; Nitric Oxide Synthase; Obesity; Probability; Random Allocation; Reference Values; Reverse Transcriptase Polymerase Chain Reaction; RNA; Thalidomide; Treatment Outcome; Tumor Necrosis Factor-alpha | 2010 |